Nicholas Buss

1.0k total citations
22 papers, 735 citations indexed

About

Nicholas Buss is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Nicholas Buss has authored 22 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Genetics. Recurrent topics in Nicholas Buss's work include Virus-based gene therapy research (3 papers), HIV Research and Treatment (3 papers) and S100 Proteins and Annexins (3 papers). Nicholas Buss is often cited by papers focused on Virus-based gene therapy research (3 papers), HIV Research and Treatment (3 papers) and S100 Proteins and Annexins (3 papers). Nicholas Buss collaborates with scholars based in United States, United Kingdom and Sweden. Nicholas Buss's co-authors include Lolke de Haan, Mary McFarlane, Jacintha Shenton, Simon J. Henderson, Felicity N. E. Gavins, Julia C. Buckingham, Paul M. Holloway, Stephen J. Getting, Michele Fiscella and J Michael Kilby and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Nicholas Buss

21 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Buss United States 12 402 219 135 90 80 22 735
Manoj Tyagi India 19 862 2.1× 175 0.8× 76 0.6× 22 0.2× 91 1.1× 79 1.3k
Christoph Schröder Germany 21 407 1.0× 184 0.8× 263 1.9× 38 0.4× 71 0.9× 49 1.1k
E Schuller France 18 222 0.6× 124 0.6× 206 1.5× 58 0.6× 85 1.1× 86 835
Jie Huang China 15 265 0.7× 86 0.4× 108 0.8× 63 0.7× 22 0.3× 101 806
Atul Tyagi United Kingdom 19 1.1k 2.7× 76 0.3× 81 0.6× 33 0.4× 119 1.5× 71 1.9k
Caroline Graham United States 17 490 1.2× 48 0.2× 174 1.3× 51 0.6× 79 1.0× 24 868
Gita Singh United States 5 380 0.9× 52 0.2× 207 1.5× 42 0.5× 42 0.5× 8 773
Jens M. Moll Germany 19 435 1.1× 86 0.4× 521 3.9× 74 0.8× 89 1.1× 32 1.3k
Wenjiang Ma China 16 266 0.7× 57 0.3× 200 1.5× 37 0.4× 25 0.3× 37 812

Countries citing papers authored by Nicholas Buss

Since Specialization
Citations

This map shows the geographic impact of Nicholas Buss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Buss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Buss more than expected).

Fields of papers citing papers by Nicholas Buss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Buss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Buss. The network helps show where Nicholas Buss may publish in the future.

Co-authorship network of co-authors of Nicholas Buss

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Buss. A scholar is included among the top collaborators of Nicholas Buss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Buss. Nicholas Buss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moffit, Jeffrey S., et al.. (2025). Nonclinical strategies and considerations to enable the redosing of gene therapies. Molecular Therapy — Methods & Clinical Development. 33(3). 101520–101520. 1 indexed citations
2.
Belur, Lalitha R., Kelley F. Kitto, Ou Li, et al.. (2024). Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I. Molecular Therapy — Methods & Clinical Development. 32(4). 101369–101369.
3.
Rensing, Nicholas, Hemanth R. Nelvagal, Joshua T. Dearborn, et al.. (2023). Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse model. Journal of Clinical Investigation. 133(12). 5 indexed citations
4.
Buss, Nicholas, Lisa G. Lanigan, Derek D. Cissell, et al.. (2022). Characterization of AAV-mediated dorsal root ganglionopathy. Molecular Therapy — Methods & Clinical Development. 24. 342–354. 46 indexed citations
5.
6.
George, Richard T. De, Liron Abuhatzira, Sotirios K. Karathanasis, et al.. (2021). MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport. Journal of the American Heart Association. 10(13). e014572–e014572. 22 indexed citations
7.
Raichlen, Joel S., Amy Pointon, Paul Hockings, et al.. (2020). Drug-induced myocardial dysfunction – recommendations for assessment in clinical and pre-clinical studies. Expert Opinion on Drug Safety. 19(3). 281–294. 2 indexed citations
8.
Ding, Kun, Jikui Shen, Sean F. Hackett, et al.. (2019). AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression. Journal of Clinical Investigation. 129(11). 4901–4911. 109 indexed citations
9.
Buss, Nicholas, Jean‐Martin Lapointe, Lolke de Haan, et al.. (2018). Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in rats. Toxicology and Applied Pharmacology. 355. 147–155. 3 indexed citations
10.
Buss, Nicholas, Patricia C. Ryan, Todd M. Baughman, et al.. (2018). Nonclinical safety and pharmacokinetics of Miglyol 812: A medium chain triglyceride in exenatide once weekly suspension. Journal of Applied Toxicology. 38(10). 1293–1301. 14 indexed citations
11.
George, Richard T. De, Dewei She, Nicholas Buss, et al.. (2017). Abstract 14664: Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of Recombinant Human Lecithin-Cholesterol Acyltransferase (MEDI6012) in Subjects With Stable Coronary Heart Disease. Circulation. 1 indexed citations
12.
Buss, Nicholas, Felicity N. E. Gavins, Patricia O. Cover, Andrea Terron, & Julia C. Buckingham. (2015). Targeting the annexin 1‐formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS‐induced pathologic changes in the murine adrenal cortex. The FASEB Journal. 29(7). 2930–2942. 16 indexed citations
13.
Buss, Nicholas, Simon J. Henderson, Mary McFarlane, Jacintha Shenton, & Lolke de Haan. (2012). Monoclonal antibody therapeutics: history and future. Current Opinion in Pharmacology. 12(5). 615–622. 315 indexed citations
14.
Gavins, Felicity N. E., et al.. (2012). Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1‐FPR2/ALX anti‐inflammatory system. The FASEB Journal. 26(12). 4977–4989. 63 indexed citations
15.
Buss, Nicholas, Scott Friedman, & James T. DeVries. (2011). Abstract 16670: Anterior Myocardial Infarction and Low Ejection Fraction: Should We Anticoagulate?. Circulation. 124(suppl_21). 1 indexed citations
16.
John, Christopher, et al.. (2008). Annexin A1 and the formyl peptide receptor family: neuroendocrine and metabolic aspects. Current Opinion in Pharmacology. 8(6). 765–776. 26 indexed citations
17.
Solomon, Solomon S., et al.. (2005). Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-α: Analysis of proteins involved in insulin resistance. Journal of Laboratory and Clinical Medicine. 145(5). 275–283. 26 indexed citations
18.
Mould, Diane R., Xiangyang Zhang, Keith Nieforth, et al.. (2005). Population pharmacokinetics and exposure-response relationship of enfuvirtide in treatment-experienced human immunodeficiency virus type 1—infected patients. Clinical Pharmacology & Therapeutics. 77(6). 515–528. 26 indexed citations
19.
Kilby, J Michael, Andrew Hill, & Nicholas Buss. (2002). The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects. HIV Medicine. 3(2). 97–104. 33 indexed citations
20.
Moyle, Graeme, et al.. (1999). Plasma and Cerebrospinal Fluid Saquinavir Concentrations in Patients Receiving Combination Antiretroviral Therapy. Clinical Infectious Diseases. 28(2). 403–404. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manoj Tyagi Breakdown of academic impact, for papers by Christoph Schröder Breakdown of academic impact, for papers by E Schuller Breakdown of academic impact, for papers by Jie Huang Breakdown of academic impact, for papers by Atul Tyagi Breakdown of academic impact, for papers by Caroline Graham Breakdown of academic impact, for papers by Gita Singh Breakdown of academic impact, for papers by Jens M. Moll Breakdown of academic impact, for papers by Wenjiang Ma
Rankless by CCL
2026